Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783262509> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2783262509 endingPage "2516" @default.
- W2783262509 startingPage "2516" @default.
- W2783262509 abstract "2516 Prostate cancer is the most commonly diagnosed non-skin malignancy and the second leading cause of cancer related deaths in US men. The majority of patients present with localized hormone dependent disease. Following progression or in those presenting with regional or metastatic disease, androgen ablation is often temporally successful in preventing or delaying progression of disease. However, approximately 70% of patients’ eventually progress to hormone refractory prostate cancer (HRPC). Multiple mechanisms of progression to HRPC have been proposed including mutations in the androgen receptor (AR), over-expression of AR and promiscuous activation via growth factor signaling pathways. Previously presented data demonstrates the activation of both the PI3K/Akt/mTOR and AR pathways in a hormone dependent prostate cancer model (LNCaP cells). In the current studies, we have shown that HRPC models have significantly increased activation of the mTOR pathway compared to hormone dependent LNCaP models. We have also identified a compensatory signaling mechanism and cross-talk pathway between AR and PI3K/Akt/mTOR pathway using co-immunoprecipitation of Akt and AR. Inhibition of mTOR via Rapamycin and RAD-001 resulted in decreased p-mTOR (Ser2448) and a 40% increase of AR protein expression at 1 hour in treated cell lysates. RAD-001 has similar properties to rapamycin, though it is more potent (IC50=54pM) in hormone dependent prostate cancer cells. RAD-001 also significantly increased (4 fold) androgen regulated promoter activation compared to vehicle treated controls. Competitive binding studies have shown no significant changes in binding to the AR, confirming RAD-001 does not bind to the AR and is not agonistic. Combination treatment with VN/124-1, a novel anti-androgen synthesized in our lab, and RAD-001 demonstrated significant inhibition of cell proliferation in a HRPC model. Increased activation of p-mTOR in HRPC models as well as compensatory signaling and cross-talk mechanisms between the AR and mTOR pathways in hormone dependent prostate cancer models provide compelling evidence to implicate this pathway as a mechanism in the progression to HRPC. A better understanding of the mechanisms of disease progression will allow for the development of targeted treatments that may delay, re-sensitize or prevent HRPC." @default.
- W2783262509 created "2018-01-26" @default.
- W2783262509 creator A5025943203 @default.
- W2783262509 creator A5067963625 @default.
- W2783262509 creator A5072945710 @default.
- W2783262509 creator A5085992065 @default.
- W2783262509 date "2007-05-01" @default.
- W2783262509 modified "2023-09-28" @default.
- W2783262509 title "Cross talk between the PI3K/Akt/mTOR pathway and the androgen receptor in hormone dependent prostate cancer and its implication in the progression to androgen independence" @default.
- W2783262509 hasPublicationYear "2007" @default.
- W2783262509 type Work @default.
- W2783262509 sameAs 2783262509 @default.
- W2783262509 citedByCount "0" @default.
- W2783262509 crossrefType "journal-article" @default.
- W2783262509 hasAuthorship W2783262509A5025943203 @default.
- W2783262509 hasAuthorship W2783262509A5067963625 @default.
- W2783262509 hasAuthorship W2783262509A5072945710 @default.
- W2783262509 hasAuthorship W2783262509A5085992065 @default.
- W2783262509 hasConcept C121608353 @default.
- W2783262509 hasConcept C126322002 @default.
- W2783262509 hasConcept C134018914 @default.
- W2783262509 hasConcept C185592680 @default.
- W2783262509 hasConcept C2777911890 @default.
- W2783262509 hasConcept C2779723316 @default.
- W2783262509 hasConcept C2780192828 @default.
- W2783262509 hasConcept C502942594 @default.
- W2783262509 hasConcept C61367390 @default.
- W2783262509 hasConcept C62478195 @default.
- W2783262509 hasConcept C71315377 @default.
- W2783262509 hasConcept C71924100 @default.
- W2783262509 hasConcept C75217442 @default.
- W2783262509 hasConcept C86554907 @default.
- W2783262509 hasConcept C86803240 @default.
- W2783262509 hasConcept C95444343 @default.
- W2783262509 hasConceptScore W2783262509C121608353 @default.
- W2783262509 hasConceptScore W2783262509C126322002 @default.
- W2783262509 hasConceptScore W2783262509C134018914 @default.
- W2783262509 hasConceptScore W2783262509C185592680 @default.
- W2783262509 hasConceptScore W2783262509C2777911890 @default.
- W2783262509 hasConceptScore W2783262509C2779723316 @default.
- W2783262509 hasConceptScore W2783262509C2780192828 @default.
- W2783262509 hasConceptScore W2783262509C502942594 @default.
- W2783262509 hasConceptScore W2783262509C61367390 @default.
- W2783262509 hasConceptScore W2783262509C62478195 @default.
- W2783262509 hasConceptScore W2783262509C71315377 @default.
- W2783262509 hasConceptScore W2783262509C71924100 @default.
- W2783262509 hasConceptScore W2783262509C75217442 @default.
- W2783262509 hasConceptScore W2783262509C86554907 @default.
- W2783262509 hasConceptScore W2783262509C86803240 @default.
- W2783262509 hasConceptScore W2783262509C95444343 @default.
- W2783262509 hasLocation W27832625091 @default.
- W2783262509 hasOpenAccess W2783262509 @default.
- W2783262509 hasPrimaryLocation W27832625091 @default.
- W2783262509 hasRelatedWork W1964618117 @default.
- W2783262509 hasRelatedWork W2030402361 @default.
- W2783262509 hasRelatedWork W2057300149 @default.
- W2783262509 hasRelatedWork W2064425366 @default.
- W2783262509 hasRelatedWork W2077807612 @default.
- W2783262509 hasRelatedWork W2103347688 @default.
- W2783262509 hasRelatedWork W2107204247 @default.
- W2783262509 hasRelatedWork W2127782142 @default.
- W2783262509 hasRelatedWork W2133173963 @default.
- W2783262509 hasRelatedWork W2160609128 @default.
- W2783262509 hasRelatedWork W2246768075 @default.
- W2783262509 hasRelatedWork W2532154357 @default.
- W2783262509 hasRelatedWork W2590128314 @default.
- W2783262509 hasRelatedWork W2740620335 @default.
- W2783262509 hasRelatedWork W2793155346 @default.
- W2783262509 hasRelatedWork W2887096573 @default.
- W2783262509 hasRelatedWork W2916401593 @default.
- W2783262509 hasRelatedWork W2977137283 @default.
- W2783262509 hasRelatedWork W3045706461 @default.
- W2783262509 hasRelatedWork W3092074436 @default.
- W2783262509 hasVolume "67" @default.
- W2783262509 isParatext "false" @default.
- W2783262509 isRetracted "false" @default.
- W2783262509 magId "2783262509" @default.
- W2783262509 workType "article" @default.